The Top Penny Stock to Buy Now Is Due for a 382% Breakout

Wearable devices will continue to merge with daily life through 2020. You probably know by now that it's more than just watches - our top penny stock to buy right now is a company that plugs directly into your brain.

And it's awaiting a 382% catalyst.

Penny stocks usually trade for around $5 or less. Their low price allows them to take more significant percentage leaps on a regular day than, say, an Apple Inc. (NASDAQ: AAPL) or Amazon.com Inc. (NASDAQ: AMZN).

The share price on penny stocks is typically more responsive to a recent event or trend related to the company. With penny stocks involved in technology or healthcare, you can often look for successful test data or FDA approval to double or triple the stock price.

For example, BioNano Genomics Inc. (NASDAQ: BNGO) shot up 107.33% almost immediately after one of its technologies was adopted by the University of Iowa last year.

Our penny stock today has the potential to nearly quadruple that gain.

No, it's not the Neuralink - Elon Musk's brain-computer interface, which is testing this year. In fact, this might even be more valuable.

This company is meeting an urgent need in a market of 217 million people, and its technology could change life as we know it.

Like the Neuralink, the technology is testing in 2020, right on pace with the next generation of wearables. That is, it's more than a step counter or a blood pressure gauge. And it's certainly not a vanity item.

You can bet this technology will eventually be connected to millions of brains worldwide.

That's why the average analyst predicts a gain of 382% for our penny stock this year. It's highly likely if the technology gets approved by the FDA. But the initial price surge is just the beginning.

You might not have seen this coming...

The Top Penny Stock to Buy Now

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

The World Health Organization estimates there are about 217 million vision-impaired people in the world. And they're the market for our top penny stock today.

Second Sight Medical Products Inc. (NASDAQ: EYES) is an "artificial sight" company. It makes glasses that act as eyes for people who are almost completely blind.

Second Sight helps people who have lost sight from glaucoma, diabetes, and other forms of cancer or trauma. The company boasts that its technology can overcome almost every form of blindness on earth through a process called "neuromodulation."

Neuromodulation uses electricity to pass stimulus through the nerves, targeting specific neurological sites in the body. In this case, it's targeting the parts of the brain responsible for vision.

You should know that Second Sight's latest financials aren't pretty to look at - its revenue has slipped 48% in the last year. But the reason behind this could make the company significantly more profitable in the future...

In 2019, Second Sight shifted its attention from selling the Argus II, its latest tech, to developing a new product - Orion. It's the first-ever human cortical implant, expected to widen this company's treatable population.

The former product, the Argus II, only worked for people whose cortex was still intact. But Orion bypasses the eyes entirely, delivering images straight to the brain.

That means virtually anyone without sight could regain it through Orion.

And we're catching Second Sight right at the peak of its research & development efforts. In fact, R&D spending has gone up 44% since the start of 2018.

And it could reap the fruits of that R&D spending in 2020, because it's on its way to getting FDA approval.

In November 2019, just two months ago, Second Sight reached an agreement with the FDA to proceed with a trial of its new Orion implant.

It will run the trials in 2020. And if the technology gains FDA approval, it could more than quadruple the stock price.

That's why the average Wall Street analyst gives it a 12-month growth target of $18 per share.

You can buy it today for just $3.73 for 382% profit potential down the road.

These Penny Pot Stocks Could Mint the Next Generation of Millionaires

We're tracking a group of tiny-but-mighty companies currently trading for just a few dollars apiece. And they're harboring an extraordinary amount of upward potential.

It doesn't matter if you're still getting familiar with legal cannabis, or if you've never invested a cent before in your life.

As long as you know how to make your next move count, you could pocket 1,000% gains - virtually overnight.

Right now, our top cannabis recommendations are trading for just a few dollars each. These share prices may never be as low as they are right now.

But they could let you conquer America's fastest-growing industry with ease.

And even though most folks wait their entire lives to find a ground-floor opportunity like this, today you can place yourself way ahead of the pack.

Click here to find out how you can access ALL of our top penny pot stock recommendations.

Follow Money Morning onFacebook and Twitter.